David Klug
Founder/CEO, Panacea Diagnostics
Adaptable diagnostic platform delivering precise, quantitative, high-throughput organoid biomarker analysis using single-molecule ELISA, alongside low-cost, rapid point-of-care diagnostics enabling 3-minute readouts and 20× multiplexing
Events David Klug has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026